Aspergillosis in immunocompromised patients with haematological malignancies

Area of Science:

• Mycology
• Infectious Diseases
• Otolaryngology

Background:

• Aspergillosis is a fungal infection that can cause severe paranasal sinus destruction, particularly in immunocompromised individuals.
• While rare in immunocompetent hosts, invasive aspergillosis poses a significant threat due to potential spread to vital structures.
• Patients with hematologic malignancies face an increasing incidence of Aspergillus sinusitis.

Purpose of the Study:

• To review new data on invasive aspergillosis in patients with hematologic malignancies.
• To highlight the diagnostic challenges and importance of histopathology in Aspergillus sinusitis.
• To emphasize the critical role of early diagnosis and antifungal therapy in patient outcomes.

Main Methods:

• Review of clinical presentation, diagnostic modalities (rhinoscopy, endoscopy, CT/MRI, cultures, histopathology), and management strategies.
• Analysis of epidemiological trends and risk factors in immunocompromised patients, specifically those with hematologic malignancies.
• Synthesis of current data on the incidence, diagnosis, and treatment of invasive aspergillosis in the context of hematologic malignancies.

Main Results:

• Aspergillus sinusitis can be misdiagnosed as tumors or inflammatory conditions due to non-specific symptoms.
• Histopathological confirmation is essential for accurate diagnosis.
• Early diagnosis combined with specific antifungal agents improves management and prognosis.

Conclusions:

• Invasive aspergillosis is a serious, potentially fatal complication in immunocompromised patients, particularly those with hematologic malignancies.
• Prompt and accurate diagnosis, supported by histopathology, is critical.
• Effective management relies on early detection and appropriate antifungal therapy, significantly improving patient prognosis.